Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplant for Malignant Disease

NCT02061800 is registered in ClinicalTrials.gov with Diane George as lead sponsor.

NCT NCT02061800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02061800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplant for Malignant Disease
Lead sponsor
Diane George
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 3, 2013
Completion date
July 31, 2026
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia (all), acute myelogenous leukemia (aml), chronic myeloid leukemia (cml), juvenile myelomonocytic leukemia (jmml), lymphoma (hodgkin's and non-hodgkin's), myelodysplastic syndrome (mds)